Ace Blend, a science-led nutrition company, has raised $9.91 million in a Series A2 funding round led by 3one4 Capital, a venture capital firm whose portfolio includes Licious, Darwinbox and Kapiva.

Existing investor Fireside Ventures, an early-stage investor in consumer brands, has increased its backing after leading Ace Blend’s $3.3 million pre-Series A round.

The new funds will support research-led product development and the commercial launch of patented nutrition formats, with the first expected in the fourth quarter of FY27.

Founded in 2018 following more than a decade of research, Ace Blend develops supplements targeting heart health, immunity, sleep, recovery and brain health.

Co-founder Saif Mehkri joined in 2022, bringing nearly three decades of experience in the nutrition industry.

The company said its approach starts with clinical evidence, using research to determine a nutrient’s form, dose and delivery rather than building products around popular ingredients. It also controls sourcing, formulation and manufacturing, while clinical validation and automated testing are conducted by accredited laboratories in Europe.

Partnerships with ingredient suppliers DSM and TCI give it exclusive rights in India to certain technologies, according to the company.

Ace Blend claims 300% growth in FY26, with more than 46% of its customers returning to purchase.

Fireside Ventures principal Ankita Balotia cited repeat purchases and word of mouth as evidence of consumer trust. However, repeat buying alone does not independently establish a supplement’s clinical effectiveness.

3one4 Capital managing partner Pranav Pai said the company was “tackling the hardest problems in nutrition”, including developing formulations suited to Indian needs and maintaining consistent quality.

Source link